PMH20 IMPACT OF DISEASE SEVERITY ON DURATION OF HOSPITALIZATION IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH OLANZAPINE OR HALOPERIDOL IN GERMANY- POST-HOC ANALYSIS OF DATA COLLECTED IN THE GEO STUDY
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74739-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)74739-2/fulltext
Title :
PMH20 IMPACT OF DISEASE SEVERITY ON DURATION OF HOSPITALIZATION IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH OLANZAPINE OR HALOPERIDOL IN GERMANY- POST-HOC ANALYSIS OF DATA COLLECTED IN THE GEO STUDY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74739-2&doi=10.1016/S1098-3015(10)74739-2
First page :
Section Title :
Open access? :
No
Section Order :
668